Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Vaccines are playing an increasingly important role in disease prevention. It is common knowledge that biological agents are unstable in the storage process, which will reduce the safety and effectiveness of biomedical products. With vaccine identity testing, vaccine purity testing, and vaccine microbial testing, Creative Biolabs also perform vaccine stability testing in accordance with the WHO specification on vaccine stability, which is adopted by the Expert Committee on Biological Standardization (ECBS), we are committed to proving that vaccine product with obvious merits such as acceptable quality, efficacy, and safety under certain storage conditions.
Creative Biolabs not only provides a general vaccine stability assessment but also offers one-stop stability assessment services for vaccine production and subsequent use.
Our vaccine cold chain technology can effectively reduce the sensitivity of vaccines to environmental temperature.
We provide customized design services for vaccine research according to the needs of customers.
In the data analysis, we offer scientific statistical methods, that is, testing a certain index at different points in a period of time, evaluating the final results statistically, conducting the average calculation and data analysis.
Proteins and other macromolecules are sensitive to heat, light, radiation, environmental changes, or may interact with container materials or other components of a vaccine mixture. Therefore, identifying their relationships and optimizing stability from production to administration to patient are extremely significant and meaningful for vaccine development. Even under the most ideal conditions, its effectiveness may gradually weaken with the passage of time since production.
We offer a variety of analytical techniques for stability testing:
Creative Biolabs has high-quality vaccine production management norms, production workshops, and strict biosafety equipment, as well as relevant research support services. We are committed to providing you with satisfactory vaccine stability detection technology.
Please feel free to contact us and get more detailed information.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
